Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(85)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(106)
- Bcl-xL(8)
- c-RET(9)
- IAP(26)
- KEAP1-Nrf2(64)
- MDM2(12)
- p53(112)
- PC-PLC(4)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(6)
- Thymidylate Synthase(10)
- TNF-α(128)
- Other Apoptosis(885)
- APC(5)
- PD-1/PD-L1 interaction(60)
- ASK1(3)
- PAR4(2)
- RIP kinase(50)
- FKBP(19)
- Pyroptosis(30)
- Cat.No. 产品名称 Information
-
GC18392
Cellocidin
乙炔二羰酰胺
An antibiotic -
GC18363
Mca-DEVDAPK(Dnp)-OH
Caspase-3 Fluorogenic Substrate III, CPP32 Fluorogenic Substrate III, 7-Methoxycoumarin-4-acetyl-DEVDAPK(Dnp)-OH, Mca-Asp-Glu-Val-Asp-Ala-Pro-Lys(Dnp)-OH
A caspase-3 fluorogenic substrate -
GC18315
Calpain Inhibitor VI
SJA6017
A calpain and cathepsin inhibitor - GC18308 UNC569 A TAM family kinase inhibitor
-
GC18241
Lysophosphatidylcholines
L-溶血卵磷脂,Lyso-Lecithins (egg)
A glycerophospholipid -
GC18226
Ac-LEHD-AMC (trifluoroacetate salt)
Ac-Leu-Glu-His-Asp-AMC, Caspase-9 Substrate
A caspase-9 fluorogenic substrate - GC18206 WT161 A potent inhibitor of HDAC6
-
GC18177
WEHI-345
N-[2-[4-氨基-3-(4-甲基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基]-2-甲基丙基]-4-吡啶甲酰胺
An inhibitor of RIPK2 - GC18173 TM5441 A PAI-1 inhibitor
-
GC12861
Z-VAD-FMK
氟甲基酮,Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone,Z-Val-Ala-Asp(OMe)-FMK
Z-VAD-FMK(苄氧羰基-Val-Ala-Asp(OMe)氟甲基酮),是一种类似ICE的蛋白酶抑制剂,通过阻止CPP32转化为其活性形式来抑制细胞凋亡。 -
GC11302
Hinokitiol
桧木醇; β-Thujaplicin
A tropolone with diverse biological activities -
GC10520
Dextran sulfate sodium salt (M.W 200000)
硫酸葡聚糖钠盐
A sulfated polysaccharide
-
GC15168
Urolithin A
尿石素A
A metabolite of ellagic acid with diverse biological activities
-
GC13400
Ac-VDVAD-AFC
N-Acetyl-Val-Asp-Val-Ala-Asp-7-amino-4-Trifluoromethylcoumarin Caspase-2 Substrate (Fluorogenic)
A fluorogenic substrate for caspase-2 -
GC13859
Z-DEVD-AFC
Caspase-3 Fluorogenic Substrate IV
A caspase-3 fluorogenic substrate - GC12367 CM-272 An inhibitor of G9a, GLP, and DNA methyltransferases
-
GC16037
7BIO
7-Bromoindirubin-3’-oxime
A caspase-independent (nonapoptotic) cell death inducer -
GC15267
Se-Aspirin
Selenium-acetylsalicylic Acid
A selenium-NSAID hybrid - GC14791 F16 A potential antitumor agent
- GC13058 NK 252 A Nrf2 activator
- GC13034 ML-291 An activator of apoptosis through UPR
-
GC10628
nor-NOHA (acetate)
Nω-hydroxy-nor-Arginine
nor-NOHA(醋酸盐)(α-氨基酸 N(omega) -Hydroxy-Nor-L-arginine)是一种有效且可逆的选择性精氨酸酶抑制剂,nor-NOHA(醋酸盐)的效力大约是 40 倍NOHA 抑制未受刺激的小鼠巨噬细胞催化 l-精氨酸水解为 l-鸟氨酸(nor-NOHA IC(50) 值 12 77777#177;5µM。 -
GC12223
Z-Asp-CH2-DCB
Z-Asp-2,6-Dichlorobenzoyloxymethyl Ketone
A pan-caspase inhibitor -
GC14847
Psoralidin
补骨脂定
A furanocoumarin with anti-cancer activity -
GC17632
Maslinic Acid
山楂酸; Crategolic acid; 2α-Hydroxyoleanolic acid
Maslinic Acid是一种五环三萜酸,广泛存在于橄榄和其他植物中。Maslinic Acid具有抗炎、抗氧化、抗肿瘤、降血糖和神经保护等多种生物活性。 -
GC15457
Pyridoxine
吡哆醇; Pyridoxol
A 4-methanol form of vitamin B6 -
GC10951
Ac-DEVD-CMK
Ac-Asp-Glu-Val-Asp-CMK,Caspase-3 Inhibitor III
An inhibitor of caspase-3 -
GC17602
Ac-DEVD-AFC
AC-ASP-GLU-VAL-ASP-7-氨基-4-三氟甲基香豆素,N-Acetyl-Asp-Glu-Val-Asp-7-amido-4-Trifluoromethylcoumarin,Caspase-3 Substrate (Fluorogenic)
A fluorogenic caspase subsrate -
GC11716
SIRT1/2 Inhibitor IV
Cambinol,NSC 112546,SIRT1 Inhibitor II,SIRT2 Inhibitor VI
Cell-permeable inhibitor of SIRT1 and SIRT2 -
GC11217
CUR 61414
G-856
A potent inhibitor of hedgehog-induced activity -
GC15613
p-nitro-Cyclic Pifithrin-α
Cyclic pifithrin-α-p-nitro,p-nitro-Cyclic PFT-α
A cell-permeable form of cyclic PFT-α - GC15258 GN25 Inhibits p53-Snail binding
-
GC14411
Apoptozole
Apoptosis Activator VII
An inhibitor of Hsp70 -
GC14016
Sulforaphane
萝卜硫素
萝卜硫素 (SFN) 称为 [1-isothiocyanato-4-(methylsulfinyl)butane]。
-
GC16625
CDDO-TFEA
CDDO-Trifluoethyl Amide,RTA 404,TP-500
A synthetic triterpenoid with potent anticancer and neuroprotective activity -
GC17119
8-Prenylnaringenin
8-异戊烯基柚皮素
A phytoestrogen -
GC12639
NS3694
Apoptosis Inhibitor II
An inhibitor of apoptosome formation and caspase activation -
GC16375
(±)-Jasmonic Acid methyl ester
甲基茉莉酮酸酯,(±)-Methyl Jasmonate
A plant growth regulator -
GC11988
15-acetoxy Scirpenol
15-乙酰蛇形菌素
A trichothecene mycotoxin -
GC10661
Destruxin B
黑僵菌素 B
An insecticidal mycotoxin - GC15225 COTI-2 An activator of mutant forms of p53
-
GC11989
Nortriptyline (hydrochloride)
盐酸去甲替林; Desmethylamitriptyline hydrochloride; Desitriptilina hydrochloride
A tricyclic antidepressant - GC13194 RPI-1 A RET kinase inhibitor
-
GC14355
CRT5
CRT0066051
A pan PKD inhibitor -
GC10022
SP 141
6-甲氧基-1-(萘-1-基)-9H-吡啶并[3,4-B]吲哚,AGN-PC-0D106I
An inhibitor of MDM2 -
GC17649
Mebendazole
甲苯咪唑
A broad-spectrum anthelmintic that inhibits microtubules -
GC15812
p-nitro-Pifithrin-α
p-nitro-PFT-α
A cell-permeable inactivator of p53 -
GC16661
Citrinin
桔霉素; NSC 186
Citrinin是一种具有多种生物活性的霉菌毒素,由青霉属、曲霉属和红曲霉属的几种真菌菌株产生。 -
GC16409
Oligomycin B
寡霉素 B
A nonselective inhibitor of the mitochondrial F1FO ATP synthase - GC10040 Arylquin 1 A Par-4 secretagogue